Risk Factors Update Summary
- The company has outstanding $20 million aggregate principal amount of 2024 Notes, reduced from $75 million.
- The company had a net income of $8 million in 2023, a significant increase from previous losses.
- The company had more than 80 patents as of December 31, 2023, down from over 90 patents.
- The company had approximately 633,409 shares of common stock available for future grants, reduced from 738,409 shares.
- The company had approximately 15.2 million shares of common stock reserved for issuance upon conversion of 2024 Notes, down from 21 million shares.
- The company had approximately 13.6 million shares of common stock reserved for issuance through the sale of equity securities, reduced from 14 million shares.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1006281&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.